Company profile
AffyImmune Therapeutics company profile
AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The Company’s proprietary technology may significantly improve the existing CAR-T cell therapy by extending the target of CAR-T therapies to solid tumors using a novel molecule and tuning down the affinity from picomolar to micromolar level to lower the on-target off-tumor toxicity.
Business identity
- Website
- https://affyimmune.com/
- Phone number
- (617) 699-1965
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2016-01-01
Headquarters
- Headquarters
- Calumet City, Illinois, United States
- Postal code
- 02458
- Country code
- US
- Continent
- North America